Showing 421 - 440 results of 629 for search '(( 13 1 decrease ) OR ( 10 ((peter decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.17s Refine Results
  1. 421
  2. 422
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Conversely, patients with non-heart failure-related polypharmacy had increased risks of ICU admissions (aOR=1.78, 95% CI: 1.13 – 2.70). ConclusionIn an examination of a database of patients with chronic heart failure, major non-heart failure-related polypharmacy was associated with increased risks in intensive care admissions. …”
    Get full text
    Get full text
    Get full text
  20. 440